ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Pernix Therapeutics Holdings
0.2070
0.0000
成交量:
- -
成交额:
- -
市值:
300.27万
市盈率:
-0.03
高:
0.2070
开:
0.2070
低:
0.2070
收:
0.2070
数据加载中...
总览
公司
新闻
公告
公司资料
公司名字:
Pernix Therapeutics Holdings
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
- -
官网:
http://www.pernixtx.com
邮编:
- -
电话:
- -
传真:
- -
简介:
Pernix Therapeutics Holdings, Inc.于1996年11月8日在马里兰州注册成立。公司是一家特种药物生产企业,主要对一系列品牌及基因医药产品进行售卖、市场营销、生产和研发,这些医药产品主要应用于失眠、细菌感染以及咳嗽和感冒症状。公司希望通过酌情把其产品推销给内科医生、卫生保健行业从业者以及顾客,以此来预见公司业绩的持续增长。自成立之日起,公司便参与了多项并购重组以及许可证协议,以此希望扩大其产品销售渠道。作为其部分扩张战略,公司计划对其他产品和公司进行战略收购,同时研发并引进额外产品,其目的是将慢性、非季节性的特种产品引入到其利润范围中。其品牌产品包括先力腾(CEDAX),它是治疗中耳炎的抗生素类药物,同时也是治疗咳嗽和感冒的处方药(包括ZUTRIPRO, REZIRA和VITUZ)。公司还对多赛平(SILENOR)进行市场营销,该物可以治疗失眠症(对睡眠维持有困难),同时不受买卖控制。公司通过售卖及市场营销组织宣传其品牌药物。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PTX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTX\",,,,,undefined,":{"symbol":"PTX","market":"US","secType":"STK","nameCN":"Pernix Therapeutics Holdings","latestPrice":0.207,"timestamp":1552680000000,"preClose":0.207,"halted":0,"volume":0,"delay":0,"floatShares":13322183,"shares":14505848,"eps":-6.260195,"marketStatus":"盘前交易","change":0,"latestTime":"07-22 04:59:33 EDT","open":0.207,"high":0.207,"low":0.207,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-6.260195,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753191000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":855291600000,"exchange":"NASDAQ","adjPreClose":0.207,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTX\",,,,,undefined,":{"symbol":"PTX","floatShares":13322183,"roa":"--","roe":"--","lyrEps":-7.205398,"shares":14505848,"dividePrice":0,"high":0.207,"amplitude":0,"preClose":0.207,"low":0.207,"week52Low":0.203,"pbRate":"-0.01","week52High":3.3,"institutionHeld":0.7448,"latestPrice":0.207,"eps":-6.260195,"divideRate":0,"volume":0,"delay":0,"ttmEps":-6.260195,"open":0.207,"prevYearClose":0.207},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.pernixtx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":0.058},{"period":"3month","weight":0.1925},{"period":"6month","weight":0.0368},{"period":"1year","weight":0.1453},{"period":"ytd","weight":0.0728}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pernix Therapeutics Holdings, Inc.于1996年11月8日在马里兰州注册成立。公司是一家特种药物生产企业,主要对一系列品牌及基因医药产品进行售卖、市场营销、生产和研发,这些医药产品主要应用于失眠、细菌感染以及咳嗽和感冒症状。公司希望通过酌情把其产品推销给内科医生、卫生保健行业从业者以及顾客,以此来预见公司业绩的持续增长。自成立之日起,公司便参与了多项并购重组以及许可证协议,以此希望扩大其产品销售渠道。作为其部分扩张战略,公司计划对其他产品和公司进行战略收购,同时研发并引进额外产品,其目的是将慢性、非季节性的特种产品引入到其利润范围中。其品牌产品包括先力腾(CEDAX),它是治疗中耳炎的抗生素类药物,同时也是治疗咳嗽和感冒的处方药(包括ZUTRIPRO, REZIRA和VITUZ)。公司还对多赛平(SILENOR)进行市场营销,该物可以治疗失眠症(对睡眠维持有困难),同时不受买卖控制。公司通过售卖及市场营销组织宣传其品牌药物。","exchange":"NASDAQ","name":"Pernix Therapeutics Holdings","nameEN":"Pernix Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PTX\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-08","symbol":"PTX","fiscalQuarterEnding":"2018/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"","actualEps":-0.89},{"market":"US","date":"2018-08-09","symbol":"PTX","fiscalQuarterEnding":"2018/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"","actualEps":-1.13},{"market":"US","date":"2018-05-10","symbol":"PTX","fiscalQuarterEnding":"2018/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"","actualEps":-1.57},{"market":"US","date":"2018-03-08","symbol":"PTX","fiscalQuarterEnding":"2017/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1520485200000,"reportTimeType":"","actualEps":-2.78},{"market":"US","date":"2017-11-07","symbol":"PTX","fiscalQuarterEnding":"2017/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1510030800000,"reportTimeType":"","actualEps":-0.57}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTX\",market:\"US\",delay:false,,,undefined,":{}}}